Quest Diagnostics Dividends and Buybacks
Dividend criteria checks 5/6
Quest Diagnostics is a dividend paying company with a current yield of 1.85% that is well covered by earnings.
Key information
1.9%
Dividend yield
0.6%
Buyback Yield
| Total Shareholder Yield | 2.4% |
| Future Dividend Yield | 1.8% |
| Dividend Growth | 7.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$3.200 |
| Payout ratio | 28% |
Recent dividend and buyback updates
Quest Diagnostics (NYSE:DGX) Will Pay A Larger Dividend Than Last Year At $0.80
Apr 03
Quest Diagnostics (NYSE:DGX) Will Pay A Larger Dividend Than Last Year At $0.80
Mar 20Quest Diagnostics (NYSE:DGX) Is Increasing Its Dividend To $0.80
Feb 27Recent updates
Quest Diagnostics (NYSE:DGX) Will Pay A Larger Dividend Than Last Year At $0.80
Apr 03Quest Diagnostics (NYSE:DGX) Will Pay A Larger Dividend Than Last Year At $0.80
Mar 20Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?
Mar 17Quest Diagnostics (NYSE:DGX) Is Increasing Its Dividend To $0.80
Feb 27Quest Diagnostics (NYSE:DGX) Has Some Way To Go To Become A Multi-Bagger
Feb 19Quest Diagnostics Incorporated (NYSE:DGX) Yearly Results: Here's What Analysts Are Forecasting For This Year
Feb 02Quest Diagnostics: Good Growth Prospects, But Little To No Upside Left At Current Valuation
Jan 28Quest Diagnostics Incorporated (NYSE:DGX) Could Be Riskier Than It Looks
Jan 26Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Dec 18Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?
Nov 30Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)
Nov 12Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Oct 25Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat
Oct 24Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E
Oct 23Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly
Oct 15These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well
Aug 30
Expanding Geographic Footprint And Advancing Diagnostics Fuel Revenue And Margin Growth
Aug 21 Strategic expansions and acquisitions, like LifeLabs in Canada and select U.S. lab assets, aim to grow market share and access, potentially boosting revenues.Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?
Aug 12Quest Diagnostics: Beat Down After Beating Q2 Estimates
Jul 28The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)
Jul 12Quest Diagnostics: On A Quest For Growth
Jul 12Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14Quest Diagnostics: Let's Keep Waiting
May 08Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Quest Diagnostics: Moving Past Covid
Oct 25Stability and Growth of Payments
Fetching dividends data
Stable Dividend: DGX's dividends per share have been stable in the past 10 years.
Growing Dividend: DGX's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Quest Diagnostics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (DGX) | 1.9% |
| Market Bottom 25% (US) | 1.7% |
| Market Top 25% (US) | 5.0% |
| Industry Average (Healthcare) | 2.0% |
| Analyst forecast (DGX) (up to 3 years) | 1.8% |
Notable Dividend: DGX's dividend (1.85%) is higher than the bottom 25% of dividend payers in the US market (1.72%).
High Dividend: DGX's dividend (1.85%) is low compared to the top 25% of dividend payers in the US market (5.07%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (28%), DGX's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (33.6%), DGX's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/22 13:46 |
| End of Day Share Price | 2025/04/22 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Quest Diagnostics Incorporated is covered by 46 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Brian Kemp Dolliver | Avondale Partners |
| Eric Coldwell | Baird |